Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 0.02% · short 7.1% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for TETRALOGIC PHARMACEUTICALS Corp only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
48 buys11 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Gerber Sandertrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| State of New Jersey Common Pension Fund D | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LAZARD ASSET MANAGEMENT LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| GEODE CAPITAL MANAGEMENT LP | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| State of New Jersey Common Pension Fund D | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gerber Sandertrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TELEMETRY SECURITIES, L.L.C. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| NOMURA SECURITIES INTERNATIONAL, INC. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TELEMETRY SECURITIES, L.L.C. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LAZARD ASSET MANAGEMENT LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Whitebox Combined Partners LPtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LAZARD ASSET MANAGEMENT LLC | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gerber Sandertrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| GEODE CAPITAL MANAGEMENT LP | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| NOMURA SECURITIES INTERNATIONAL, INC. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| NOMURA SECURITIES INTERNATIONAL, INC. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Whitebox Combined Partners LPtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| TELEMETRY SECURITIES, L.L.C. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| GEODE CAPITAL MANAGEMENT LP | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| State of New Jersey Common Pension Fund D | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Linden Capital L.P. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Linden Capital L.P. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Linden Capital L.P. | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Whitebox Combined Partners LPtrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Clarus Ventures II GP, L.P. | Sell | $19.6K | SEC |